Molecular Genetic Pathology Fellowship

What Molecular Genetic Pathology Fellows Actually Do

Molecular genetic pathology (MGP) is a laboratory-based subspecialty built around one core task: interpreting genetic and genomic variation and translating that interpretation into clinically actionable information. Fellows spend the majority of their time doing work that does not look like traditional pathology—there are no glass slides in the conventional sense, and patient contact is largely consultative rather than procedural.

On any given day, a fellow might:

• Interpret next-generation sequencing (NGS) panels for somatic tumor variants—calling pathogenic, likely pathogenic, or variant of uncertain significance (VUS) classifications against curated databases and primary literature
• Review germline hereditary cancer panels or constitutional chromosomal microarray results and draft variant reports for ordering clinicians
• Troubleshoot a wet-lab assay failure upstream of the bioinformatics pipeline—because fellows are expected to understand the full analytical chain from extraction to variant call
• Attend molecular tumor boards alongside oncologists, genetic counselors, and clinical geneticists, defending variant classifications and treatment-relevant interpretations in a multidisciplinary room
• Field consults from clinicians who received a report they do not understand—translating variant-level information into clinical language
• Contribute to laboratory test development or validation studies, particularly at academic centers rolling out new assay platforms

The intellectual throughline is ambiguity management. A substantial fraction of variants encountered in practice cannot be cleanly classified. Fellows learn to synthesize population frequency data, functional evidence, segregation studies, and computational predictions into a defensible classification—and then document that reasoning transparently enough that it can be audited, updated, or challenged as evidence evolves.

This is not a fellowship where you wait for a clear answer to emerge. You are frequently the person who constructs the answer from imperfect data, signs your name to it, and accepts that the answer may need revision when better evidence arrives.

The Two-Board Reality: AP/CP + Medical Genetics

MGP is one of the few fellowships in US graduate medical education jointly accredited by two separate bodies: ACGME and the American College of Medical Genetics and Genomics (ACMG). This dual structure reflects the fellowship's identity as a genuine bridge specialty, and it has a direct consequence for who can apply.

Eligibility requires board certification or eligibility in one of two primary specialties:

• Anatomic and Clinical Pathology (AP/CP) or Anatomic Pathology (AP) alone, via an ACGME-accredited pathology residency
• Medical Genetics and Genomics, via an ACGME-accredited medical genetics residency

In practice, the large majority of MGP fellows arrive through the pathology pipeline. Medical genetics trainees who pursue MGP are a smaller but meaningful cohort, and they bring a different foundational skill set—deeper clinical genetics grounding, less laboratory operations exposure—that programs value for different reasons.

If you are a PGY-0 student today, the decision you are making is not yet "apply to MGP." It is "which residency to enter and why." That upstream decision determines your pipeline. AP/CP residency is the conventional path. It gives you the broadest base—clinical laboratory medicine, surgical pathology, autopsy—and positions you for most pathology fellowships. AP-only residency is possible but narrows your options at the margins; verify current program-specific requirements before assuming equivalence.

The medical genetics route into MGP is intellectually coherent but structurally less common. If you are drawn to the clinical genetics side of this work—counseling families, managing hereditary syndrome patients—medical genetics residency followed by MGP fellowship is a legitimate path that produces a genuinely different professional than the pathology route does.

Personality and Cognitive Fit Profile

MGP selects, over time, for a specific cognitive style. This is not gatekeeping language—it is practical information for assessing whether you will find the work energizing or draining five years into practice.

Comfort with unresolved ambiguity. Variant classification is probabilistic, not binary. The ACMG/AMP classification framework gives you a structured scaffold, but it does not eliminate judgment calls. Trainees who need definitive answers to feel competent find this uncomfortable. Trainees who find probabilistic reasoning intellectually satisfying find it generative.

Logic-oriented pattern recognition. The bioinformatics layer of MGP is not optional—even at programs where dedicated bioinformaticians run pipelines, fellows need enough fluency to interrogate outputs critically, recognize artifact patterns, and understand what a pipeline cannot see. You do not need to be a programmer, but you need to be comfortable thinking computationally.

Detail orientation with high consequence tolerance. A misclassified germline variant in a hereditary cancer panel can send a family down a preventive surgery pathway that is not indicated. The stakes of precision are real and sustained. People who thrive in this environment tend to find precision intrinsically satisfying rather than burdensome.

Cross-disciplinary synthesis. You will be expected to speak to oncologists about therapeutic implications, to genetic counselors about inheritance patterns, to laboratorians about assay performance, and to hospital administrators about test utilization. The ability to modulate technical depth for different audiences is a professional competency in this field, not a soft skill.

Low need for direct patient interaction. If what energizes you most in medicine is the patient relationship—the exam room, the longitudinal care, the moment of diagnosis with a person in front of you—MGP will likely feel like an incomplete professional life. Consultative involvement exists, but it is indirect and report-mediated for most of the work.

How This Fellowship Compares to Other Pathology Subspecialties

Choosing MGP over other pathology fellowships is a meaningful fork, and the comparison is worth making explicitly.

MGP vs. Cytogenetics
There is significant conceptual overlap—both involve chromosomal and genomic interpretation. Traditional cytogenetics (karyotype, FISH) is increasingly integrated into or superseded by NGS-based platforms in many high-volume molecular labs. MGP training typically includes cytogenomics content. If you are drawn primarily to chromosomal structural analysis and classical cytogenetics methodology, a dedicated cytogenetics fellowship remains a distinct path. If you want the broadest genomic toolkit with molecular emphasis, MGP is the stronger fit.

MGP vs. Hematopathology
Hematopathology has a large molecular component—MRD testing, fusion transcripts, somatic mutational profiling—but it is anchored in morphology, immunophenotyping, and clinical correlation with hematologic malignancy. Hematopathologists interpret bone marrows and lymph node biopsies. MGP fellows do not. If you want to be the person who signs out the AML bone marrow, that is hematopathology. If you want to be the person who interprets the FLT3 and NPM1 assay that informs treatment on that same patient, MGP is the role.

MGP vs. Clinical Informatics
Clinical informatics fellowship attracts physicians interested in health IT infrastructure, EHR systems, and population-level data. MGP attracts physicians interested in the genomic data itself—the biology, the variant interpretation, the clinical genomics translation. There is some overlap in computational thinking, but the work products and career trajectories are substantially different. If your interest is in genomic data pipelines specifically rather than health systems informatics broadly, MGP is the more targeted fit.

MGP vs. Molecular Pathology (non-board-certified track)
Some pathologists complete informal molecular pathology training without pursuing the formal MGP board certification. The MGP fellowship provides a structured, ACGME/ACMG-accredited pathway with defined competencies and dual board eligibility. For anyone intending to direct a molecular diagnostic laboratory or practice clinical genomics with a formal credentialing basis, the accredited fellowship is the appropriate route.

Pre-Residency Steps That Actually Matter

PGY-0 is early to commit to MGP, but it is not too early to build foundational exposure that compounds across residency training. The moves that matter are concrete and low-risk to pursue even if your specialty interests evolve.

• Take a human genetics or medical genetics course if you have not already. Basic Mendelian genetics, chromosomal biology, and inheritance patterns are the vocabulary of this field. Gaps at this level create friction in every downstream rotation. This is correctable now and harder to correct during residency.
• Get bioinformatics exposure at an introductory level. This does not mean a computer science degree. It means working through a structured introduction to sequence data formats, variant calling concepts, and database querying. MOOCs from verified academic providers (Coursera, edX) in genomic data science are a reasonable starting point. The goal is conceptual fluency, not software engineering proficiency.
• Shadow or rotate through a molecular pathology or clinical genomics laboratory. The physical environment and operational reality of a molecular diagnostic lab is not intuitive from textbook descriptions. Time in a functioning lab—watching how specimens flow, how variant reports are generated, how quality control works—is valuable context before residency applications require you to articulate why you want this path.
• Choose AP/CP over AP-only residency deliberately. If MGP is a live option for you, AP/CP provides clinical laboratory medicine exposure—clinical chemistry, microbiology, blood banking—that is directly relevant to understanding molecular laboratory operations within a health system. It also keeps more fellowship options open. If you are certain you want only surgical pathology and MGP, AP-only is still a viable route, but make that choice explicitly rather than by default.
• Seek research exposure in genomics, variant interpretation, or computational biology. This does not require a publication before medical school graduation. It requires demonstrating genuine engagement—even a summer project, a capstone, or meaningful volunteer work in a genetics or genomics lab—that gives you something substantive to discuss in applications and interviews.

Research Signals Programs Want to See

MGP programs are evaluating whether you have engaged seriously with the intellectual content of the field, not whether you have accumulated publication volume for its own sake. The signal they are reading for is genuine familiarity with how genomic data is generated, interpreted, and applied clinically.

Research that reads well in this context includes:

• Genomics or variant interpretation projects—studies that involved NGS data, variant classification challenges, or population-level genomic analysis
• Computational or bioinformatics work—pipeline development, tool benchmarking, or database curation projects, even at a trainee contribution level
• Molecular pathology case reports or case series—particularly those involving diagnostic challenges in somatic or germline interpretation
• Translational projects connecting genomic findings to clinical outcomes in oncology, hereditary disease, or pharmacogenomics

Research that does not read as strongly—not because it is poor science, but because it does not demonstrate field-specific engagement—includes basic bench science unconnected to genomics, clinical outcomes research in non-genetics domains, or global health and education projects. These are not liabilities; they are simply neutral relative to field-specific work when programs are assessing your intellectual investment in molecular genetics.

A single well-characterized genomics project in which you understood the variant interpretation questions is more persuasive than a longer publication list in unrelated areas. Programs in this field read abstracts carefully and will ask you to walk through your methods.

Residency Choices That Open or Close This Door

Your residency choice is the most consequential structural decision for MGP eligibility, and it deserves deliberate analysis rather than default drift.

AP/CP pathology residency is the dominant feeder. It provides the broadest platform: you rotate through molecular pathology, genetics consultation services, hematopathology with molecular components, and clinical laboratory subspecialties. By the end of AP/CP residency, you have context for every service that intersects with the MGP lab. You also sit for both AP and CP boards, satisfying the primary specialty eligibility requirement cleanly.

Program characteristics that predict strong MGP positioning:

• Residency programs with an active molecular pathology rotation—not a brief observership, but a genuine rotation where residents interpret cases and write reports
• Programs affiliated with NCI-designated cancer centers or large hereditary cancer programs, where germline testing volume is high and fellows are visible as collaborators
• Faculty with MGP fellowship training or active genomics research programs who can write credible, specific letters of recommendation
• Institutional infrastructure for resident research in genomics—biobanks, computational resources, collaborative faculty

What to ask on residency interviews: Ask directly whether residents have matched into MGP fellowships recently. Ask what the molecular pathology rotation involves at the case level. Ask whether any faculty hold MGP board certification. These questions are not aggressive—they are the appropriate due diligence questions for a trainee with a specific fellowship goal.

The medical genetics residency route is legitimate but requires a different residency application strategy entirely. Medical genetics residency is small, competitive, and structured around clinical genetics—managing dysmorphology, inborn errors of metabolism, cancer genetics clinics. If you arrive at MGP through this route, you bring clinical depth that pathology-trained fellows often lack, but you will likely need dedicated attention to laboratory operations during fellowship to close that gap. Neither background is superior; they produce different strengths.

The Genomic Medicine Job Market: Academic vs. Industry vs. Clinical Lab

MGP board certification opens a career landscape that is genuinely broader than most pathology subspecialties. The field sits at an intersection that multiple sectors are actively building out, which produces real optionality—with real tradeoffs.

Academic medical center molecular laboratory director. This is the conventional endpoint for most MGP-trained pathologists. The role involves clinical test interpretation and sign-out, laboratory operations and quality management, test development and validation, graduate medical education (fellows and residents), and research. At large academic centers, this is a full-time faculty position with protected research time; at smaller institutions, the laboratory director role may be combined with other laboratory medicine responsibilities. Academic practice offers intellectual depth, trainee mentorship, and research infrastructure, with the compensation structure and pace of academic medicine.

Pharma and biotech clinical genomics scientist. The pharmaceutical industry has developed substantial internal genomics infrastructure for companion diagnostic development, clinical trial biomarker programs, and precision oncology drug development. MGP-trained physicians bring regulatory credibility, clinical interpretation experience, and board certification that pure PhD scientists do not hold. These roles are typically non-clinical, non-supervisory of patient care, and compensated differently than academic or clinical positions. They often require relocation to biotech hubs and involve portfolio management across programs rather than deep individual case work.

Reference laboratory medical director. Large national reference laboratories employ molecular pathology directors at multiple levels—site directors, specialty directors, and national medical leadership. Volume in this setting is high; intellectual engagement at the individual case level may be lower than academic practice, but the operational scope and influence over testing standards nationally can be substantial. Compensation in this sector is typically above academic medicine levels.

Direct-to-consumer and clinical genomics companies. A growing number of companies in population genomics, pharmacogenomics, and consumer health employ MGP-trained physicians in medical affairs, interpretation oversight, and regulatory strategy roles. These positions vary enormously in structure and stability; the sector has experienced significant consolidation. Physicians considering this path should evaluate company-specific financials and regulatory positioning carefully rather than treating it as a stable category.

One practical note: the gap between academic and non-academic compensation in genomic medicine is substantial. This should be part of your decision calculus, not hidden beneath it. See PGY Zero's career data pages for current compensation benchmarks by sector.

Board Certification Roadmap

MGP certification involves two separate certifying bodies, and the sequencing of examinations requires planning that should start during fellowship, not after.

American Board of Pathology (ABPath). Pathology-route fellows who complete an MGP fellowship are eligible to sit for the ABPath subspecialty examination in Molecular Genetic Pathology. This examination is offered on a defined cycle; verify current examination dates and eligibility windows directly with ABPath for your application year, as these details change. ABPath certification requires maintenance through a continuing certification program—periodic assessment and continuing medical education requirements that are ongoing throughout career.

American Board of Medical Genetics and Genomics (ABMGG). The ABMGG offers a parallel certification pathway in Molecular Genetic Pathology. Fellows who trained through an ACMG-accredited program are eligible for this examination. The ABMGG certification is the primary credential for the medical genetics pipeline; pathology-route fellows may hold dual certification from both boards, which is recognized and valued particularly in settings that bridge both specialties.

Dual certification strategy. Holding both ABPath and ABMGG certification in MGP is achievable for pathology-route fellows who meet ABMGG eligibility requirements and is worth deliberate planning. It provides maximum professional flexibility—particularly for academic positions that recruit across pathology and genetics departments—and signals breadth to future employers. The added examination burden is real but manageable when timed relative to fellowship completion.

Verify current requirements, eligibility windows, and examination fees directly with ABPath (abpath.org) and ABMGG (abmgg.org) for your specific application year. Requirements have evolved as the field has matured and will likely continue to do so.

Signs This Fellowship May Not Fit You

This section is not a filter designed to screen you out. It is an honest accounting of where the work consistently creates friction, so you can make an informed decision rather than a hopeful one.

• You need resolution to feel competent. If variant-of-uncertain-significance classifications feel like professional failure rather than an accurate representation of the evidence, the psychological load of this work will accumulate. A substantial fraction of clinical genomics work lives permanently in ambiguity. This is not a temporary condition waiting for better databases—it is the nature of the field.
• Informatics feels like a necessary evil rather than a legitimate part of medicine. You can practice MGP without being a bioinformatician, but you cannot practice it while being hostile to computational thinking. Fellows who resist engaging with the data layer find themselves dependent on informatics staff in ways that limit their authority over clinical interpretation.
• Your motivation for medicine is primarily procedural or patient-facing. If what drew you to medicine was doing procedures, building longitudinal patient relationships, or making real-time clinical decisions with direct patient feedback, MGP is unlikely to sustain that motivation. The work is largely report-mediated and asynchronous in its relationship to clinical outcomes.
• You are hoping genomics will feel simpler than other pathology subspecialties. The knowledge base in MGP is expanding faster than in most medical subspecialties. The variant databases, classification criteria, assay platforms, and clinical indications all evolve continuously. Maintenance of competence requires active, ongoing engagement with primary literature and professional guidelines—not periodic review, but continuous updating.
• You want rapid autonomous clinical authority in a defined scope. MGP practitioners operate in a consultative and interpretive role that is influential but structurally positioned behind the ordering clinician. If you want to be the physician making the primary care decision, this structure will feel limiting.

Signs This Is Your Path

• You find variant interpretation genuinely interesting as a puzzle. The convergence of population genetics, functional biology, computational prediction, and clinical phenotype into a single classification decision is the core intellectual activity of the field. If working through that convergence energizes you, you have found your intellectual home.
• Precision oncology and hereditary disease capture your clinical imagination. The cases that engage MGP practitioners most deeply involve consequential genomic findings—a germline BRCA2 variant in an otherwise healthy patient, a somatic EGFR mutation that determines chemotherapy eligibility, a de novo chromosomal variant explaining a child's phenotype. If those scenarios feel like the medicine you want to do, that is a meaningful signal.
• You want to build or shape infrastructure, not just operate within it. MGP practitioners at academic and reference centers actively design testing algorithms, implement new assay platforms, develop variant curation programs, and write institutional policies on genomic data management. If you are motivated by building systems, not just functioning within them, this field gives you that scope.
• You are energized by the bridge between wet laboratory and clinical translation. MGP is one of the few fields in medicine where a single practitioner can be credible from nucleic acid extraction through clinical report interpretation. If the integrated laboratory-clinical role appeals to you—rather than feeling like you have to pick one—this field was designed for that profile.
• You want to participate in a field that is still being defined. Clinical genomics guidelines, variant classification frameworks, reimbursement structures, and scope-of-practice questions are all actively contested in this space. Trainees entering now will contribute to defining what the specialty looks like in a decade. If that feels like opportunity rather than instability, the timing is good.

Questions to Ask Yourself Before Committing

These are not rhetorical prompts. Work through each one with enough specificity to produce an actual answer.

1. When I have encountered ambiguous data in any context—scientific, clinical, or analytical—do I engage more deeply or seek to move past it? Your honest answer to this question predicts your relationship with variant classification more accurately than your interest in genetics as a subject.
2. Can I articulate what specifically interests me about molecular pathology, distinct from genomics as a broad cultural concept? "Genomics is the future" is not a fit rationale. If you cannot describe a specific interpretive or methodological problem you find interesting, your engagement with the field may be conceptual rather than operational.
3. Am I choosing MGP because I want this work, or because I am trying to avoid other pathology work? Fellows who arrive in MGP as a retreat from surgical pathology or clinical laboratory medicine often find that the interpretive intensity of molecular work is its own demanding environment. Avoidance motivation rarely survives fellowship.
4. What does my career look like at fifteen years post-training, and does MGP produce that career? Map the specific role you want—academic laboratory director, industry scientist, reference lab medical director—and work backwards. Verify that MGP certification is a required or standard credential for that role, not just a possible one.
5. Have I had any direct exposure to molecular pathology work—rotation, shadowing, or research—or am I operating entirely on secondhand information? If the answer is no direct exposure, your next concrete action is obvious. Opinions formed without operational experience are not reliable fit assessments.

Your PGY Zero Action Plan for Molecular Genetic Pathology

This is a phased checklist. Each item is concrete, completable in a defined timeframe, and tied directly to fellowship readiness. Do not treat it as aspirational—treat it as a project plan.

This semester / immediately:

• If you have not taken a formal human genetics or medical genetics course, enroll in one or identify an equivalent self-study resource and commit a timeline to completing it. This is foundational vocabulary, not elective enrichment.
• Identify one molecular pathology or clinical genetics laboratory at your institution or a nearby academic center. Contact them directly—email the laboratory director or a fellow—and ask for a half-day observational visit. Be specific about your interest in MGP. Most molecular pathology faculty are receptive to motivated PGY-0 students who ask a concrete question rather than a vague one.
• Read the current ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants (Richards et al., Genetics in Medicine, 2015) in full. It is publicly accessible. Understanding this document is baseline literacy for the field; arriving at a fellowship interview having read it carefully is a concrete signal of preparation.

Next three to six months:

• Complete an introductory bioinformatics or genomic data science course through a verified academic provider. The goal is to be able to describe what a variant calling pipeline does at a conceptual level, not to write code. Document the course completion—you will reference it in applications.
• Identify a research mentor whose work touches genomics, variant interpretation, molecular pathology, or computational biology. Approach with a specific question or project idea, not a general request for involvement. Even a defined contribution to an ongoing project is sufficient at this stage—the goal is genuine engagement with the data, not a lead authorship.
• Connect with one current MGP fellow, through institutional connections, a pathology interest group, or professional society trainee communities. Ask them one substantive question about what surprised them about fellowship—not what it is like in general, but what they did not expect. The answer will give you more useful information than any overview document, including this one.

During residency application cycle:

• Choose AP/CP pathology residency programs deliberately, with specific attention to which programs have active molecular pathology rotations, MGP-trained faculty, and documented fellowship placement in genomic subspecialties. Ask these questions on interview day, not after ranking.
• Begin shaping the narrative thread in your personal statement around the specific intellectual problems in genomic medicine that interest you. Vague enthusiasm for "the future of genomics" is not persuasive at competitive programs. A specific interpretive problem you have thought about, a case you observed, or a research question you are working on is.

Throughout residency (prospective planning):

• Treat your molecular pathology rotation as a fellowship audition, not a rotation to complete. Write thorough case logs, develop relationships with molecular pathology faculty, and seek case interpretation responsibility beyond what is required.
• Maintain your bioinformatics literacy actively—the tools and databases evolve, and a fellow who arrives with current knowledge of variant curation databases and NGS platform characteristics is immediately more useful than one who is starting from scratch.
• By your second year of residency, you should have at least one genomics-adjacent research project with a defined output—poster, manuscript, or conference presentation—that you own sufficiently to walk a fellowship program director through in detail.

MGP is a small, technically demanding, and intellectually honest subspecialty. It rewards trainees who engage with its actual content rather than its reputation, and it tends to filter out those who arrived for reasons adjacent to the work itself. If the work described on this page is the work you want to do, the path is clear and the infrastructure to pursue it exists. Start with the concrete steps, accumulate real exposure, and let actual engagement with the field—not aspirational positioning—drive the decision.